Synergy CHC (SNYR) Earnings Analysis
Synergy CHC (SNYR) next reports earnings on 2026-08-13, consensus EPS -0.01 USD. Last quarter (2026-05-14) it missed with EPS -0.23 USD vs 0.03 USD est (-866.7%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -0.11.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SNYR next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.01 USD |
| Revenue estimate | 0.01B |
SNYR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.23 USD | 0.03 USD | -866.7% | Miss |
| 2026-04-01 | -1.35 USD | 0.01 USD | -13600% | Miss |
| 2025-11-13 | 0.01 USD | 0.01 USD | 0% | Beat |
| 2025-08-14 | 0.17 USD | 0.08 USD | +112.5% | Beat |
| 2025-05-15 | 0.1 USD | 0.07 USD | +42.9% | Beat |
| 2025-03-31 | 0.01 USD | 0.1 USD | -90% | Miss |
| 2024-12-06 | 0.1 USD | 0.1 USD | 0% | Beat |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
SNYR valuation and analyst view
| Trailing P/E | -0.11 |
|---|---|
| Trailing EPS | -1.39655 USD |
| Price / book | -0.08 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is Synergy CHC (SNYR)'s next earnings date?
Synergy CHC is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.01 USD and revenue estimate of 0.01B.
Did SNYR beat earnings last quarter?
In its 2026-05-14 report, SNYR posted EPS of -0.23 USD versus a 0.03 USD estimate — a miss of 866.7%.
What is SNYR's earnings track record?
Over the last 7 reported quarters with consensus data, SNYR beat estimates 4 times (57%).
What is SNYR's current P/E ratio and EPS?
SNYR trades at a trailing P/E of -0.11 on trailing EPS of -1.3965477081133308 USD.
What do analysts rate SNYR?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.